| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |